CD8A and non-small cell lung carcinoma: This correlation highlights the importance of understanding the dynamics and functional roles of different CD8+T cell subsets in the context of ICB therapy, particularly in non–small‐cell lung cancer (NSCLC), where both CD8+TRM and CD8+TCIRCM have been identified [219].